5 FDA approval decisions to watch in the 1st quarter
Credit: Yujin Kim / MedTech Dive, original photo courtesy of U.S. Food and Drug Administration The Food and Drug Administration cleared...
Medical Mystery: It took more than 50 years to find out why his health was so poor
For as long as he can remember, Steven Knapp never felt well. “That was pretty much true from early childhood,” said Knapp, a...
New agents to fight multidrug-resistant germs
Resistance to antibiotics is on the rise worldwide. Fraunhofer scientists have joined forces with partners in the Phage4Cure project to...
CF Newborn Screening Improves Weight and Lung Outcomes, but Has No Impact on Social Inequalities, St
Babies diagnosed with cystic fibrosis (CF) through newborn bloodspot screening show better lung function, can better stave off infection...
Vertex and Republic of Ireland Reach Agreement on Reimbursement for Triple Combination Therapy
Patients with cystic fibrosis (CF) in the Republic of Ireland will be among the first in Europe to benefit from Vertex Pharmaceuticals’...
Care of Children with Bronchiectasis Lags Those with Cystic Fibrosis, Australian Study Finds
Children with bronchiectasis have poorer lung function than those with (CF), likely because of the u8differing levels of care given to...
The immune system listens in on bacteria signaling to each other
The immune response can be modulated by bacterial signaling molecules. One bacterium does not an infection cause; the microbes work as a...
IGF2R Blood Levels May Help Predict Antibiotic Response in CF Pulmonary Exacerbations, Study Says
Measuring the levels of insulin-like growth factor 2 receptor (IGF2R) during the first days of treatment with intravenous antibiotics...
Proteostasis to Test Personalized Treatment with Novel CFTR Modulators in Europe
Three investigative therapies by Proteostasis Therapeutics — PTI-801, PTI-808, and PTI-428 — showed potential to treat cystic fibrosis...
Approval of drug therapy a 'new dawn' for cystic fibrosis care in Ireland
A drug which has the potential to treat the underlying cause of cystic fibrosis for 80% of patients in Ireland has been approved by the...
